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Introduction  and  Terminology                                                                              
               Clinical   interest  in   electrocardiographic   (ECG)  phenomena   of  early   ventricular 
repolarization (EVR) has been rekindled recently mainly because of their clinically established 
association with fatal cardiac arrhythmias, particularly in otherwise healthy individuals with no 
(or minimal) structural diseases of the heart. ECG phenomena of EVR have often been 
misdiagnosed, misinterpreted, or undermined.   This happened mainly because of prevailing 
opinion of the"benign" or "misleading" nature of various EVR phenomena. For instance, early 
repolarization changes consistent with Brugada syndrome have been interpreted "innocent" and 
overlooked   for   decades   until   1992.1  Another   example   -   so-called   "early   repolarization 
syndrome" (ERS) that universally and unequivocally has been regarded as "normal", "normal 
variant", "benign early repolarization" until 2000.2  In 2008, seminal article by Haïssaguerre et 
al.3 accompanied by editorial comments by Wellens4 and letter to the editor by Nam et al.5 
brought clinical attention to an increased prevalence of the ERS among patients with a history of 
idiopathic ventricular fibrillation (VF).                                                     
            The ECG phenomena of EVR include (but not are limited to): 
•    J-deflections                                                                            
•    "Slurring or notching" of the QRS complex (with or without J-deflections)                              
•    J-waves (with or without ST-segment elevation).
            The clinical validity of ECG manifestations of EVR as makers of sudden cardiac death 
(SCD) and their utility in risk stratification are not well defined. In addition, it is common for 
such ECG phenomena to vary significantly depending upon a variety of intrinsic cardiac and 
extracardiac factors. The main focus of this review is to characterize the ECG patterns of the 
EVR with a special focus on the ERS and its arrhythmogenic potential.                            
            Ventricular repolarization begins when ventricular depolarization ends. In the normal 
heart, the evolution of depolarization into repolarization is relatively short process, and the 
magnitude of the overlap between the latest depolarization and the earliest repolarization does 
not exceed 10 msec.6 The duration of this temporal overlap between the end of depolarization 
and   the  beginning  of   repolarization  is   greatly  influenced   by   various   physiological   and 
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pathological, cardiac and extracardiac conditions that affect either: (a) propagation of the 
excitation wave through ventricular wall or (b) recovery of its excitability, or (c) both. Among 
intrinsic cardiac factors are: 
•  An intrinsic configuration of the early phase of the actions potentials in different ventricular 
layers (endomyocardium, midmyocardium, and epicardium)                                           
•     A   modification   of   the   time-course   of   repolarization   across   the   ventricular   wall 
(transventricular vector gradient).
               In   a  normal   ECG,   the   transition   of   ventricular   depolarization   into   ventricular 
repolarization corresponds on the surface ECG to the J-point. The J-point defined as the point at 
which there is abrupt transition from the QRS complex to the ST-segment. Deviation of the J-
point from the isoelectric line leads to the presence of a J-deflection, which is a common ECG 
feature of ERS, but also seen in acute myocardial ischemia, hypercalemia, and various 
intraventricular conduction disturbances. A J-deflection inscribed on either the downsloping 
limb of the QRS complex or S wave is commonly regarded as a QRS-notching, whereas a 
smooth and prolonged transition from the QRS segment to the ST segment - QRS-slurring. 
Increased amplitude and duration of the J-deflection that takes the shape of a 'dome or a hump" 
is usually described as a  J-wave.6                                                                                                 
            Noteworthy to emphasize that a clear distinction between the delayed conduction and the 
EVR cannot always be made on the basis of an ECG alone. Nevertheless, distinguishing the two 
is very important since commonly EVR presents greater arrhythmia risk than a delayed 
intraventricular conduction, especially in otherwise healthy individuals. To limited extent, 
depolarization and repolarization processes can be differentiated based by their differences with 
respect to the heart rate, different cardiac drugs, and neurotransmitters (see below). The signal-
averaged ECG could be helpful diagnostic tool but of limited clinical value in many cases,7 and 
the search for new ECG tools and markers to differentiate these two processes is accelerating.
"Slurring or Notching" of the QRS Complex                                              
            In 1998, Garg and his associates8 reported a case of "familial sudden cardiac death 
associated  with  a  terminal  QRS-abnormality  on surface 12-lead   electrocardiogram".  The 
abnormal low-amplitude deflections in the downsloping limp of the QRS complex in leads II, 
III, aVF and I, aVL and V6 were coincident with the late potential on the signal-averaged ECG. 
This deflection appeared to be more prominent after procainamide or beta-blockers and 
normalized after quinidine. Moreover, sustained polymorphic ventricular tachycardia, which 
degenerated   to   VF   was   easily  inducible   during   programmed   stimulation   from  the  right 
ventricular apex, despite administration of procainamide or atenolol. The clinical significance of 
these ECG findings is not fully understood at present and further investigation is warranted.     
J-Waves
            Different names have been used at different time for the J-wave. They include "camel 
hump sign","hathook junction", "K wave", "H wave", "late delta wave", "current of injury", "J 
point wave", "hypothermic wave", "hypothermic hump", "Osborn wave".   J-waves can be 
classified as:
•    Hypothermic                                                                                     
•     Non-hypothermic                                                                                                                                   
•    Idiopathic.
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Hypothermic J-waves                                                                                                                                 
               Clinical as well as experimental data linking hypothermic J-waves and cardiac 
arrhythmias   remain   sparse   and   somewhat   contradictory;   the   occurrence   of   ventricular 
tachyarrhythmias associated with hypothermic J-wave varies from 0 to almost 100%.9 Sodium 
channel blockers, such as procainamide and lidocaine, are ineffective, indeed proarrhythmic in 
both the prevention and treatment of the malignant ventricular tachyarrhythmias in hypothermic 
patients during their rewarming.9                                                                                                               
Non-hypothermic J-Waves                                                                                                         
            ECG changes resembling those in hypothermia-induced J-waves have been observed in a 
various clinical and experimental settings with normal body temperature,  such as acute 
myocardial ischemia, acute pulmonary thromboembolism, right ventricular infarction, electrolyte 
or metabolic disorders, pulmonary or inflammatory diseases, or abnormalities of central or 
peripheral nervous system, intoxication by heterocyclic antidepressant or cocaine, and many 
other   abnormal   conditions.10  Among   those   clinical   situations,   prominent   J-waves   most 
frequently   are   observed   in   acute   myocardial   ischemia   and   hypercalemia,   and   their 
arrhythmogenic potentials in most clinical settings are chiefly dependent upon the underlying 
disease.
Idiopathic J-Waves                                                                                               
            In the absence of any structural cardiac abnormalities or extracardiac diseases, changes of 
EVR can be classified as primary or "idiopathic". Several forms of idiopathic appearance of a J-
wave in human with or without accompanying ST-segment elevation have been described. 
Among them, the most investigated is so-called ECG marker of Brugada syndrome. Idiopathic J-
wave followed by downsloping ST-segment elevation with inverted T-waves in the right chest 
leads is an ECG hallmark of the "typical" Brugada syndrome.                                   
               However, in many clinical cases of symptomatic Brugada syndrome (atrial and/or 
ventricular tachyarrhythmias or SCD), the pattern of ST-T abnormalities and/or their ECG 
"localization" is different from that in the "typical" Brugada Syndrome. In such cases, the terms 
"atypical" or "J-wave - like' are appropriate. Clinically noteworthy that J-wave-like ECG 
abnormalities in leads other that the right precordial (e.g. inferior or lateral) ("atypical" Brugada 
syndrome) have been also described in otherwise healthy individuals prone to paroxysmal 
ventricular tachycardia/fibrillation.                                                         
Early Repolarization Syndrome                                                                                           
    
            The term "early repolarization syndrome" was introduced nearly half a century ago and 
has traditionally been regarded as idiopathic and benign or "innocent”11 or "misleading"12 ECG 
pattern of EVR until 2000.2 The ERS has been ascribed a number of names, including "early 
repolarization", "early ventricular repolarization', 'benign early repolarization", "benign J wave", 
"nonspecific changes of ventricular repolarization", "repolarization variant", "normal variant RS-
T segment elevation", and "juvenile or unconventional ST-T pattern" and cetera to describe the 
"characteristic" ECG pattern of J-deflection followed by horizontal ST-segment elevation in the 
mid-precordial leads.2                                                                                                              
            To avoid further confusion and inconsistencies with terminology, we prefer to use the 
term "early repolarization syndrome", acknowledging at the same that this term is not the best 
one to use in the cases of asymptomatic forms of EVR. By its own definition, any clinical 
syndrome is a combination  of  signs  and  symptoms  that  occur  together   and   characterize   a 
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particular abnormality. The term "syndrome" is best reserved for a description of clinical 
manifestation of the disease. In this context, the "true ERS" is best defined as an arrhythmogenic 
entity that is characterized by (a) ECG marker of ERS that is associated with (b) arrhythmogenic 
complications, including SCD, and/or family history of SCD in otherwise healthy individual.
            The prevalence of ERS varies between 1%13and 2%.14  It is more commonly seen in 
young individuals (27.5%),15 especially those predisposed to vagotonia, and shows a clear male 
preponderance (77%).13 The syndrome is also often observed in:
•    Athletes16                                                                                                                                                                                  
•    Cocaine users17                                                                                                                                                           
•   Obstructive hypertrophic cardiomyopathy18                                                                   
•  Defects and/or hypertrophy of the interventricular septum.18
               The electrocardiographic manifestation of ERS is often dependent on heart rate, 
normalizing during exercise or with rapid pacing, as well as with advancing age.19 Familial 
occurrence of the syndrome has been observed.20,21 Although early studies were interpreted to 
suggest that the syndrome is more prevalent in the Black population, more-recent studies 
challenge this notion.22                                                                                                                                                                           
            In 2000, based on preclinical experimental work from Dr. Charles Antzelevitch, it has 
been suggested that: (a) ERS should not be considered as normal or benign ECG abnormality a 
priori, unless otherwise proven, as generally thought and (b)  under certain conditions known to 
predispose to ST-segment elevation, patients with ERS may be at greater arrhythmogenic risk.2   
               The classical ECG pattern of ERS consists of: (a) prominent notch or slur on the 
downsloping portion of the QRS complex, or J-deflection, (b) followed by diffuse upward ST 
segment concavity concordant with the QRS complex, and (c) positive T wave in the same lead. 
Additional ECG feature include: 
•    Localization of the ECG pattern of ERS in scalar ECG. Mid-to-lateral precordial leads V2-
V4(5) have been recognized as showing the most prominent repolarization changes consistent 
with ERS.  Noteworthy, similar changes might appear in other leads but to a lesser extent  
•    Reciprocal ST segment depression in aVR                                                
•    "Waxing and waning" of the ST-T segment over time                                                        
•    Often, ERS is associated with shorter-than-normal QT interval duration, even adjusted to the 
heart rate.
            Nevertheless, in many clinical instances, it is still very difficult to distinguish subjects 
with ERS from those with the Brugada syndrome or various intraventricular conduction blocks, 
or Short QT syndrome based solely on a resting ECG. Furthermore, the ECG alterations in 
response to changes in heart rate, drugs effects, and autonomic tone observed in ERS are very 
similar to those observed (a) under hypothermic conditions and (b) the Brugada syndrome 
(Table 1).
Table 1: Autonomic and pharmacologic modulation of the J-wave magnitude under hypothermic 
conditions, in the early repolarization (ERS) and Brugada syndromes (BrS).
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           Many clinical features of ERS are similar to that of Brugada syndrome, including (a) 
predominance in young otherwise healthy males, (b) predisposition to familial occurrence, (c) in 
many individuals,  a transient normalization of ECG manifestation,  and (d) ERS similar 
responses to drugs and autonomic modulation.                                                           
            Two major features permit differentiation of the ECG signatures of ERS and the Brugada 
syndrome: (a) pattern and (b) leads specificity. The elevated ST-segment in ERS is usually 
localized in leads   V2-V4(5)  and has an upward concavity with positive T-wave polarity 
accompanied by a notched (or slurred) J-deflection.  In contrast, the ECG of Brugada patients 
generally displays a prominent J-point elevation (J-wave), followed by a downsloping ST 
segments and negative T-wave in the right precordial leads V1-V3 ("typical") or other leads 
("atypical").
               It is often difficult to distinguish subjects with ERS from those with the Brugada 
syndrome, especially when the latter also display intraventricular conduction slowing or block. 
In 1993, Aizawa and his colleagues23  described several patients with idiopathic ventricular 
fibrillation in whom they found "bradycardia-dependent intraventricular block". The common 
ECG features of these patients included: (a) incomplete right bundle branch block, (b) prominent 
"notch" on downsloping limb of the QRS complex in leads V3-V5, II, III, and aVF, (c) elevated 
ST segment with positive T waves leads V2-V3, and (d) rate (deceleration) - dependent 
accentuation of the prominence of the "notch".                                              
            The dynamicity of ECG changes in ERS and Brugada syndrome is also confounding. 
When the clinical history is malignant, an invasive electrophysiological study examining the 
inducibility of ventricular tachycardia/fibrillation may be useful in assessing arrhythmogenic 
risk.
               Interestingly, ECG changes consistent with the Brugada syndrome have also been 
referred to as a benign repolarization variant or "Ideiken phenomenon" for more than three 
decades and some patients having such ECG abnormalities have been described as "unwitting 
victims of electrocardiography".2                                                                                                     
            No doubt, the intrinsic capability of the standard 12-lead ECG are significantly limited in 
the differential diagnosis of the ERS, since only a small portion of the available diagnostic 
information can be obtained from conventional scalar 12-lead ECG tracings. The search for new 
additional and more advanced and sophisticated computer-assisted methodologies and ECG 
markers that can help to differentiate ST-segment elevations in ERS from other ECG phenomena 
of EVR (e.g. Brugada syndrome, acute ischemia) have intensified in most recent years. The 
"three-dimensional (3D) approach" is expected to be valuable in EVR evaluation. Some of those 
3D - ECG markers (e.g. ST-T and QRS-T angles) are already in their "clinical validation" stages 
of development (Figure 1).
Possible Cellular and Ionic Mechanisms                                                                        
            Concordant with the QRS complex, ST segment elevation is most commonly recognized 
as a sign of acute myocardial damage, often associated with the development of cardiac 
arrhythmias. The electrophysiological nature of the ST-segment elevation in ERS, whether 
idiopathic or due to so-called "current of injury", has been investigated by means of a direct-
current magnetocardiogram, which, in contrast to conventional 12-lead ECG, is capable of 
determining a TQ interval shifts. The results showed clearly that ST-segment shifts in subjects 
with ERS are unrelated to ischemic injury.24                                                        
            One might also explain the principal difference between ERS and Brugada syndrome 
based on an abbreviation of the action potential due to loss of its "dome" resulting in the 
development of a very significant transmural as well as epicardial dispersion of repolarization 
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 and refractoriness, setting the stage for both phase 2 and circus movement reentry culminating 
in much more severe arrhythmogenic manifestations of the Brugada syndrome if compared with 
ERS.2 
            Some believe that parietal (myocardial) conduction defects (delayed conduction) could 
contribute to both the ECG manifestation and the arrhythmogenic potentials of the different ECG 
phenomena of EVR.
Figure 1: Acute ischemia induces wide angle between QRS and T vector loops, but the angle remains narrow in ST 
elevation associated with early repolarization.  In acute myocardial ischemia, the QRS and T loops become widely 
divergent and the spatial angle between them is greater than 75° in a significant majority of cases.  In contrast, the 
angle is unaffected in early repolarization (from http://www.newcardio.com/)
Modulation by Drugs, Rate, and Neurotransmitters                                                    
            The changes in the magnitude of the EVR abnormalities in ERS and Brugada syndrome, 
like a hypothermic J wave, display qualitatively similar responses to a variety of drugs as well as 
to changes in rate and autonomic tone (Table 1)2:
•    Slowing of heart rate exaggerates J-waves and ST-segment elevation, while increase in heart 
rate   during   exercise   or   following   isoproterenol   reduces   or   even   eliminates   these   ECG 
abnormalities  
•    Sodium channel blockers (known to unmask the Brugada syndrome) increase ST-segment 
elevation in ERS subjects and hypothermic J-waves                                                 
•     Sympathetic stimulation and β-adrenergic  agonists normalize the ST-segment in both 
syndromes,  whereas β-adrenergic blockers augment ST-segment elevation  in both, while 
propranolol increases its magnitude and its toxicity may even induce classical pattern of ERS. 
The Role of Nervous System
            Clinical and experimental studies point to high spinal cord injury as a cause of ERS-like 
changes in the ECG.  High cervical spinal chord injury can lead to significant deterioration or 
even complete disruption of the cardiac sympathetic activity, leaving parasympathetic activity 
unopposed.25 Parasympathetic activation has an opposite effect in both syndromes, causing ST 
segment elevation due to depression or loss of the action potential plateau (see below). ECG 
patterns "wax and wane" in both syndromes, possibly due to variations of autonomic activity.2
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Arrhythmogenic Potential                                                                                                         
            In vast majority of cases, ERS is not a malignant EVR syndrome per se, unless otherwise 
proven. However, the similarities between the Brugada syndrome and ERS in response to rate, 
neuromodulation and pharmacologic agents strongly suggest a parallelism of mechanisms.  
            While ERS has long been considered to be benign, in experimental models, the ECG 
signature of ERS can be  converted  to that of the Brugada syndrome.2,26,27  This raises the 
possibility that ERS may not be as benign (unless otherwise proven) as generally believed, and 
that under certain conditions known to predispose to ST-segment elevation, ERS subjects may 
be at increased risk.  In considering these possibilities, it is instructive to remember that (a) the 
Brugada syndrome was regarded as benign for more than three decades, and (b) that one 
syndrome can be readily converted to the other in experimental models involving the wedge 
preparation.
            One hypothesis presumes that depression of the epicardial, but not endocardial, action 
potential plateau creates a transmural gradient that manifests on the scalar ECG as a complex 
ST-segment   elevation   with   a   positive   T-wave.   As   such   the   cellular   substrate   is   not 
arrhythmogenic, but in case of further increase in net repolarizing current as a result of complete 
loss of the epicardial action potential dome and the attendant development of a large transmural 
dispersion of repolarization could become arrhythmogenic. This proposed mechanism also 
explain the highly arrhythmogenic character of the Brugada syndrome and apparently benign 
exceptions.
            Alternative hypothesis is based on assumption that the delayed (parietal) intraventricular 
conduction delay in the proximity of interventricular septum (mid-precordial leads could 
contribute to the ECG phenomenon of ERS and its potential link to electrical instability.
            It is important to emphasize that these hypotheses remain to be more rigorously tested 
and that the distinct nosologic entity that is referred as the ERS needs to be more fully delineated 
within the framework of what we have learned about the Brugada syndrome in recent years. A 
careful clinical history and invasive electrophysiological studies may be required to determine 
whether or not the early ventricular repolarization abnormalities in a given patient are benign or 
malignant.
Summary, Clinical Implementation, and Future Directions                                         
               The available clinical data suggest that the different ECG phenomena of the EVR 
syndromes often share similar ECG presentations, mechanisms with wide range of their 
arrhythmogenic potentials. ECG similarities between different ECG phenomena of EVR raise 
certain concerns for their misdiagnosis and clinical relevance.                                
            In our opinion: 
1.    ERS, as a diagnosis, should not be regarded as either benign or malignant a priori unless 
otherwise proven.                                                                                                                 
2.     Clinical judgment based on clinical presentation ("arrhythmogenic" anamnesis), family 
history   or   syncope/SCD,   potential   use   of   cardio-active   drugs,   including   psychotropic 
medications is the most essential in the risk stratification of the ERS subject. Special attention 
should   be   devoted   to   the   family   history   of   primary   EVR   abnormalities   and/or   SCD.
3.     Additional   diagnostic   work-up,   such   as   tilt-test,   signal-averaging   ECG,   and 
electrophysiological studies with or without drug testing, should be considered on the case-by-
case basis upon physician's discretion. Genetic screening of ERS subjects at risk, once available, 
will be one of the most important diagnostic tools to identify and/or confirm the diagnosis of 
primary electrical abnormalities/diseases of the EVR.                                         
4.    It is important to keep in mind that ERS subjects might be predisposed to the drug-induced 
ventricular   arrhythmias.                                                                                      
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 5.    Standard 12-lead ECG is very valuable diagnostic tool to identify ERS subjects, yet its 
clinical utility in the risk stratification is of limited intrinsic value. New ECG technologies, 
methodologies, and markers should be developed and clinically validated to help to identify and 
differentiate ERS from other forms of EVR as well as to stratify this risk. 
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